Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2018
Price : $35 *
At a glance
- Drugs Nalmefene (Primary) ; Nalmefene (Primary)
- Indications Alcoholism; Opioid abuse
- Focus Pharmacokinetics
- 22 Feb 2018 Results published in an Aegis Therapeutics Media Release
- 22 Feb 2018 This trial was conducted by the National Institute on Drug Abuse (NIDA) under a clinical trial agreement with Opiant Pharmaceuticals Inc, as reported in an Aegis Therapeutics media release.
- 10 Jul 2017 Status changed from not yet recruiting to completed.